GlaxoSmithKline CEO: I Don't Define Work By My Gender

(3:)

Emma Walmsley, GSK's CEO, in a conversation with Sarah Neville

(20:30)

Distinguished Speaker Series: A Conversation with GSK CEO Emma Walmsley

(50:27)

The David Rubenstein Show: GSK CEO Emma Walmsley

(24:6)

GSK CEO Emma Walmsley on beating Q4 earnings

(4:47)

GSK CEO Emma Walmsley: Our Top Priority Is To Invest In Growth In Our Core Pharma Business | CNBC

(4:10)

Watch CNBC's full interview with GSK CEO Emma Walmsley about the Pfizer merger

(16:26)

GSK CEO Emma Walmsley | Powerful Woman | Glaxo Smith Kline | GSK

(3:58)

CNBC - Interview with GSK's CEO Andrew Witty on the 2010 Access to Medicine Index

(6:25)

Disturbing Interview With Andrew Witty (GSK)

(9:9)

Cramer: This biotech stock could be worth over $100 billion on an FDA approval

(5:19)

GSK Video Interview Questions and Answers Practice

(20:52)

BSR Conference 2014: Sir Andrew Witty, CEO GlaxoSmithKline

(55:47)

Ep 1: Getting Ahead Together with... a career in STEM

(5:31)

Emma Walmsley summarises our agreement with Pfizer to form a Consumer Healthcare Joint Venture.

(3:51)

GlaxoSmithKline (GSK) Fined $3 Billion

(6:35)

Ep 7: Getting Ahead Together with Thriving People

(6:21)

Dame Emma Walmsley: What does the CEO think?

(8:4)

GSK Demerger Explained

(9:49)

The future of oncology at GSK

(3:)

GSK tops Access to Medicine Index 2022

(2:51)

LIVE: Reuters Newsmaker with Emma Walmsley, CEO of GlaxoSmithKline

(49:9)

GSK CEO Says 14 Billion Covid Vaccine Doses May Be Needed

(1:23)

GSK’s Race to Bring an RSV Vaccine to Market: CNBC Healthy Returns Summit 2023

(23:10)

Coronavirus: VIR CEO on partnering with GSK to develop treatments, vaccines

(6:10)

Coronavirus: GlaxoSmithKline CEO on developing an 'adjuvant vaccine against COVID-19'

(1:)

GSK CEO: Pfizer venture creates value for both our consumer and pharma businesses

(7:11)